Inventor · disambiguated record
James D. Rodgers
Also filed as: RODGERS JAMES D · RODGERS JAMES DAVID
87 granted patents·17 pending applications·4,445 citations·filing 1994–2025
99Inventor score
Files withINCYTE CORP50RODGERS JAMES D16INCYTE HOLDINGS CORP8BRISTOL MYERS SQUIBB PHARMA CO7DU PONT PHARM CO7
Top patents by PatentIndex Score
104 records- 0199US11331320B2Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitorsINCYTE CORP·Filed 2020·Granted May 17, 2022·12 cites·21 claims
- 0299US10639310B2Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitorsINCYTE CORP·Filed 2018·Granted May 5, 2020·20 cites·6 claims
- 0399US10398699B2Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitorsINCYTE CORP·Filed 2018·Granted Sep 3, 2019·31 cites·7 claims
- 0499US9974790B2Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as janus kinase inhibitorsINCYTE CORP·Filed 2016·Granted May 22, 2018·40 cites·14 claims
- 0599US9938294B2Tricyclic heterocycles as BET protein inhibitorsINCYTE CORP·Filed 2017·Granted Apr 10, 2018·24 cites·14 claims
- 0699US9623029B23-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]octane- or heptane-nitrile as JAK inhibitorsINCYTE CORP·Filed 2015·Granted Apr 18, 2017·44 cites·11 claims
- 0799US9079912B2Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as Janus kinase inhibitorsINCYTE CORP·Filed 2014·Granted Jul 14, 2015·75 cites·6 claims
- 0899US8829013B1Salts of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrileINCYTE CORP·Filed 2014·Granted Sep 9, 2014·91 cites·14 claims
- 0999US8822481B1Salts of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d] pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrileINCYTE CORP·Filed 2014·Granted Sep 2, 2014·89 cites·28 claims
- 1099US8722693B2Salts of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrileINCYTE CORP·Filed 2013·Granted May 13, 2014·143 cites·10 claims
- 1199US8604043B23-[4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitorsLI YUN-LONG·Filed 2010·Granted Dec 10, 2013·117 cites·20 claims
- 1299US8530485B2Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitorsRODGERS JAMES D·Filed 2011·Granted Sep 10, 2013·98 cites·10 claims
- 1399US8445488B2Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as Janus kinase inhibitorsRODGERS JAMES D·Filed 2011·Granted May 21, 2013·98 cites·9 claims
- 1499US8158616B2Azetidine and cyclobutane derivatives as JAK inhibitorsRODGERS JAMES D·Filed 2009·Granted Apr 17, 2012·170 cites·3 claims
- 1599US8053433B2Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitorsINCYTE CORP·Filed 2007·Granted Nov 8, 2011·107 cites·15 claims
- 1699US7598257B2Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitorsINCYTE CORP·Filed 2006·Granted Oct 6, 2009·328 cites·8 claims
- 1799US7335667B2Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-4-yl-amines as Janus kinase inhibitorsINCYTE CORP·Filed 2005·Granted Feb 26, 2008·149 cites·38 claims
- 1898US11213528B2Salts of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrileINCYTE HOLDINGS CORP·Filed 2020·Granted Jan 4, 2022·5 cites·16 claims
- 1998US10464947B2Tricyclic heterocycles as BET protein inhibitorsINCYTE CORP·Filed 2018·Granted Nov 5, 2019·17 cites·56 claims
- 2098US9662335B2Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as janus kinase inhibitorsINCYTE CORP·Filed 2016·Granted May 30, 2017·25 cites·6 claims
- 2198US9376439B2Salts of the janus kinase inhibitor (R)-3(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrileINCYTE CORP·Filed 2014·Granted Jun 28, 2016·62 cites·26 claims
- 2298US9359358B2Cyclohexyl azetidine derivatives as JAK inhibitorsRODGERS JAMES D·Filed 2012·Granted Jun 7, 2016·81 cites·30 claims
- 2398US9216984B23-[4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl]octane—or heptane-nitrile as JAK inhibitorsINCYTE CORP·Filed 2013·Granted Dec 22, 2015·56 cites·26 claims
- 2498US9090611B2Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitorsINCYTE CORP·Filed 2014·Granted Jul 28, 2015·60 cites·32 claims
- 2598US8946245B2Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitorsRODGERS JAMES D·Filed 2011·Granted Feb 3, 2015·70 cites·26 claims
- 2698US8933086B2Heteroaryl substituted pyrrolo[2,3-B]pyridines and pyrrolo[2,3-B]pyrimidines as Janus kinase inhibitorsINCYTE CORP·Filed 2013·Granted Jan 13, 2015·71 cites·7 claims
- 2798US8933085B2Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitorsRODGERS JAMES D·Filed 2011·Granted Jan 13, 2015·96 cites·39 claims
- 2898US8835423B2Azepine inhibitors of janus kinasesINCYTE CORP·Filed 2013·Granted Sep 16, 2014·71 cites·33 claims
- 2998US8741895B2Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as Janus kinase inhibitorsINCYTE CORP·Filed 2013·Granted Jun 3, 2014·84 cites·32 claims
- 3098US8716303B2N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitorsRODGERS JAMES D·Filed 2010·Granted May 6, 2014·109 cites·74 claims
- 3198US8541425B2Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitorsRODGERS JAMES D·Filed 2009·Granted Sep 24, 2013·92 cites·7 claims
- 3298US8420629B2Azetidine and cyclobutane derivatives as JAK inhibitorsRODGERS JAMES D·Filed 2011·Granted Apr 16, 2013·105 cites·2 claims
- 3398US8415362B2Pyrazolyl substituted pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitorsRODGERS JAMES D·Filed 2008·Granted Apr 9, 2013·117 cites·21 claims
- 3498US8410265B2Processes for preparing JAK inhibitors and related intermediate compoundsZHOU JIACHENG·Filed 2010·Granted Apr 2, 2013·136 cites·4 claims
- 3598US8309718B24-pyrazolyl-N-arylpyrimidin-2-amines and 4-pyrazolyl-N-heteroarylpyrimidin-2-amines as janus kinase inhibitorsLI YUN-LONG·Filed 2008·Granted Nov 13, 2012·109 cites·35 claims
- 3697US11498926B2Tricyclic heterocycles as BET protein inhibitorsINCYTE CORP·Filed 2020·Granted Nov 15, 2022·4 cites·73 claims
- 3797US10919912B2Tricyclic heterocycles as BET protein inhibitorsINCYTE CORP·Filed 2019·Granted Feb 16, 2021·10 cites·29 claims
- 3897US10610530B2Salts of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrileINCYTE HOLDINGS CORP·Filed 2018·Granted Apr 7, 2020·8 cites·28 claims
- 3997US9334274B2N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitorsINCYTE CORP·Filed 2014·Granted May 10, 2016·57 cites·34 claims
- 4097US9227985B2Tricyclic heterocycles as bet protein inhibitorsINCYTE CORP·Filed 2014·Granted Jan 5, 2016·40 cites·14 claims
- 4197US9206187B2Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as Janus kinaseINCYTE CORP·Filed 2013·Granted Dec 8, 2015·55 cites·26 claims
- 4297US9034884B2Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as JAK inhibitorsRODGERS JAMES D·Filed 2011·Granted May 19, 2015·91 cites·36 claims
- 4397US8889697B2Metabolites of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrileRODGERS JAMES D·Filed 2010·Granted Nov 18, 2014·79 cites·6 claims
- 4497US8841318B2Substituted heterocycles as janus kinase inhibitorsINCYTE CORP·Filed 2013·Granted Sep 23, 2014·72 cites·14 claims
- 4596US10975085B2Process for preparing a composition comprising an enantiomeric excess of greater than or equal to 90% of the (R)-enantiomer of a compound of formula IIIINCYTE HOLDINGS CORP·Filed 2019·Granted Apr 13, 2021·5 cites·8 claims
- 4696US10364248B2Processes for preparing 4-chloro-7H-pyrrolo[2,3-d]pyrimidineINCYTE HOLDINGS CORP·Filed 2018·Granted Jul 30, 2019·5 cites·13 claims
- 4796US9814722B2Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as janus kinase inhibitorsINCYTE CORP·Filed 2016·Granted Nov 14, 2017·13 cites·30 claims
- 4896US9309246B2Tricyclic heterocycles as BET protein inhibitorsINCYTE CORP·Filed 2014·Granted Apr 12, 2016·33 cites·32 claims
- 4996US9249145B2Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitorsRODGERS JAMES D·Filed 2010·Granted Feb 2, 2016·45 cites·56 claims
- 5096US8748401B2Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrileRODGERS JAMES D·Filed 2013·Granted Jun 10, 2014·80 cites·11 claims
Showing the top 50 of 104 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when James D. Rodgers files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →